SANTA CLARA, Calif.--(BUSINESS WIRE)--Nov 7, 2023--<em>HeartBeam, In</em><em>c.</em> (NASDAQ: BEAT), a cardiac technology company that has developed the first and only credit card-size, portable 3D-vector electrocardiogram (VECG) platform ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Nov 7, 2023--Grace Science, LLC announced today that it has received FDA clearance of its Investigational New Drug (IND) application for GS-100, an AAV9 gene replacement therapy for the treatment of NGLY1 Deficiency.The clinical trial will utilize a ...
CHICAGO--(BUSINESS WIRE)--Nov 7, 2023--MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA” or the “Company”), a clinical-stage biopharmaceutical company developing telomere-targeting immunotherapies for cancer, today reported financial results for the third quarter ended September ...
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Nov 7, 2023--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave ® System, today announced that management will participate in three upcoming investor conferences in November.Sonendo management is scheduled to ...
BURLINGTON, Mass.--(BUSINESS WIRE)--Nov 7, 2023--Cardurion Pharmaceuticals, Inc. (“Cardurion” or “the Company”), a clinical-stage biotechnology company focused on the discovery and development of novel, next-generation therapeutics for the treatment of cardiovascular diseases, today ...